Pulished Date August, 2019
ID: 1501
Share on
Share on

Antivenom Market By Type, By Animal, And By Region - Global Growth, Trends, And Forecast To 2024

Pulished: August, 2019
ID: 1501
Pages: 175

Antivenom Market Overview

Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 100,000 people die worldwide with snake bites annually. To overcome poisonous effects after venomous bites the global manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.

Antivenom Market Forecast Report (2019-2024)

Global Antivenom Market is expected to reach USD $1.9 billion by 2024 from USD $2.6 billion in 2019, growing at a CAGR of 6.18% during the forecast period 2019-2024.

Antivenom Market Growth

Increasing government initiations to promote the development of high-quality antivenom products, the presence of the highest number of snake bite victims (especially from Asia & Africa regions), and estimated pipeline products launch is driving the growth of global Antivenom Market. In addition, the growing of deaths from venomous animal’s bites and increasing research to develop advanced antivenom products are further stimulating the growth of global Antivenom Market. However, withdrawal of antivenom products, insufficient funding to develop the antivenom products to meet demand, the high cost of the products, regulatory complexities, and high costs of maintaining livestock for antivenom production are restraining the growth of global Antivenom Market.

Antivenom Market Segmentation

The Global Antivenom Market Size is broadly categorized into type and animal. On the basis of type, global Antivenom market Growth is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on the animal the market is segmented into Snakes, Scorpions, Spiders, and Others.

On the basis of geography, the global market is analyzed under various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle-East & Africa. North America is the dominating market for Antivenom accounting for a share of approximately 39.0% followed by Europe in 2016. Asia-Pacific is estimated to be the fastest growing region with a CAGR of 8.59% during the forecast period of 2018-2023.

Key Developments in the Market

  • May 2017: Snakebite911, an app that contains educational information on snakes and snakes bite first-aid support, developed by BTG PLC.

Major Key Players

Key market players in the global Antivenom Market

  • Instituto Bioclon, S.A. de C.V. (Mexico),
  • Pfizer AG (Switzerland),
  • CSL Limited (Australia),
  • F. Hoffmann-La Roche Ltd. (Switzerland),
  • Merck & Co., Inc. (U.S.),
  • Rare Disease Therapeutics, Inc. (U.S.),
  • Vins Bioproducts Limited (India),
  • BTG Plc (U.K.),
  • Incepta Vaccine Ltd. (Bangladesh),
  • Bharat Serum

Reasons to Purchase this Report

  • Current and future global Antivenom Market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • Identifying the segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

1. Introduction                        

            1.1 Market Definition            

            1.2 Study Deliverables                       

            1.3 Base Currency, Base Year and Forecast Periods              

            1.4 General Study Assumptions                     

2. Research Methodology

            2.1 Introduction                     

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research         

                        2.2.3 Econometric Modelling

                        2.2.4 Expert Validation          

            2.3 Analysis Design                

            2.4 Study Timeline                

3. Overview

            3.1 Executive Summary                     

            3.2 Key Inferences                 

            3.3 Epidemology                    

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

            4.1 Market Drivers                 

            4.2 Market Restraints            

            4.3 Key Challenges                 

            4.4 Current Opportunities in the Market                  

5. Market Segmentation

            5.1 Type                     

                        5.1.1 Introduction      

                        5.1.2 Vaccines

                        5.1.3 Hyperimmune Sera       

                                    5.1.3.1 Homologous

                                    5.1.3.2 Heterologous

                        5.1.4  Y-o-Y Growth Analysis, By type            

                        5.1.5  Market Attractiveness Analysis, By Type         

                        5.1.6  Market Share Analysis, By Type           

            5.2 Animal                  

                        5.2.1 Introduction      

                        5.2.2 Snakes   

                        5.2.3 Scorpions           

                        5.2.4 Spiders  

                        5.2.5 Others   

                        5.2.6  Y-o-Y Growth Analysis, By Animal       

                        5.2.7  Market Attractiveness Analysis, By Animal     

                        5.2.8  Market Share Analysis, By Animal       

6. Geographical Analysis

            6.1 Introduction                     

                        6.1.1 Regional Trends

                        6.1.2 Impact Analysis 

                        6.1.3 Y-o-Y Growth Analysis  

                                    6.1.3.1 By Geographical Area

                                    6.1.3.2 By Type

                                    6.1.3.2 By Animal

                        6.1.4  Market Attractiveness Analysis

                                    6.1.4.1 By Geographical Area

                                    6.1.4.2 By Type

                                    6.1.4.2 By Animal

                        6.1.5  Market Share Analysis 

                                    6.1.5.1 By Geographical Area

                                    6.1.5.2 By Type

                                    6.1.5.2 By Animal

            6.2 North America                 

                        6.1.1 Introduction      

                        6.1.2 United States    

                        6.1.3 Canada  

            6.3 Europe                  

                        6.2.1 Introduction      

                        6.2.2 U.K         

                        6.2.3 Spain     

                        6.2.4 Germany

                        6.2.5 Italy       

                        6.2.6 France   

            6.4 Asia-Pacific                       

                        6.3.1 Introduction      

                        6.3.2 China     

                        6.3.3 India      

                        6.3.4 Japan     

                        6.3.5 Australia

                        6.3.6 South Korea      

            6.5 Latin America                   

                        6.4.1 Introduction      

                        6.4.2 Brazil     

                        6.4.3 Argentina          

                        6.4.4 Mexico  

                        6.4.5 Rest of Latin America   

            6.6 Middle East & Africa                    

                        6.5.1 Introduction      

                        6.5.2 Middle-East       

                        6.5.3 Africa    

7.Strategic Analysis                            

            7.1 PESTLE analysis                

                        7.1.1 Political 

                        7.1.2 Economic          

                        7.1.3 Social     

                        7.1.4 Technological    

                        7.1.5 Legal     

                        7.1.6 Environmental  

            7.2 Porter’s Five analysis                   

                        7.2.1 Bargaining Power of Suppliers  

                        7.2.2 Bargaining Power of Consumers          

                        7.2.3 Threat of New Entrants

                        7.2.4 Threat of Substitute Products and Services     

                        7.2.5 Competitive Rivalry within the Industry           

8.Market Leaders' Analysis                            

            8.1 Instituto Bioclon, S.A. de C.V.                  

                        8.1.1 Overview           

                        8.1.2 Product Analysis

                        8.1.3 Financial analysis          

                        8.1.4 Recent Developments   

                        8.1.5 SWOT analysis  

                        8.1.6 Analyst View     

            8.2 Pfizer AG              

            8.3 CSL Limited                      

            8.4 Roche                   

            8.5 Merck & Co                      

            8.6 Rare Disease Therapeutics, Inc.               

            8.7 Vins Bioproducts Limited             

            8.8 BTG Plc                 

            8.9 Incepta Vaccine Ltd                      

            8.10 Bharat Serim and Vaccines Limited (BSV)                     

9. Competitive Landscape                              

            9.1 Market share analysis                  

            9.2 Merger and Acquisition Analysis             

            9.3 Agreements, collaborations and Joint Ventures             

            9.4 New Product Launches                

10. Market Outlook and Investment Opportunities                           

Appendix                                

            a) List of Tables

            b) List of Figures

  • Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Diabetes Care Devices Market By Region, From 2019-2024 ( USD Billion )
  2. Global Antivenom Market By Type, From 2019-2024 ( USD Billion )
  3. Global Vaccines Market By Region, From 2019-2024 ( USD Billion )
  4. Global Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  5. Global Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  6. Global Snakes Market By Region, From 2019-2024 ( USD Billion )
  7. Global Scorpions Market By Region, From 2019-2024 ( USD Billion )
  8. Global Spiders Market By Region, From 2019-2024 ( USD Billion )
  9. Global Others Market By Region, From 2019-2024 ( USD Billion )
  10. North America Antivenom Market By Type, From 2019-2024 ( USD Billion )
  11. North America Vaccines Market By Region, From 2019-2024 ( USD Billion )
  12. North America Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  13. North America Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  14. North America Snakes Market By Region, From 2019-2024 ( USD Billion )
  15. North America Scorpions Market By Region, From 2019-2024 ( USD Billion )
  16. North America Spiders Market By Region, From 2019-2024 ( USD Billion )
  17. North America Others Market By Region, From 2019-2024 ( USD Billion )
  18. United States Antivenom Market By Type, From 2019-2024 ( USD Billion )
  19. United States Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  20. Canada Antivenom Market By Type, From 2019-2024 ( USD Billion )
  21. Canada Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  22. Europe Antivenom Market By Type, From 2019-2024 ( USD Billion )
  23. Europe Vaccines Market By Region, From 2019-2024 ( USD Billion )
  24. Europe Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  25. Europe Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  26. Europe Snakes Market By Region, From 2019-2024 ( USD Billion )
  27. Europe Scorpions Market By Region, From 2019-2024 ( USD Billion )
  28. Europe Spiders Market By Region, From 2019-2024 ( USD Billion )
  29. Europe Others Market By Region, From 2019-2024 ( USD Billion )
  30. U.K. Antivenom Market By Type, From 2019-2024 ( USD Billion )
  31. U.K. Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  32. Germany Antivenom Market By Type, From 2019-2024 ( USD Billion )
  33. Germany Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  34. France Antivenom Market By Type, From 2019-2024 ( USD Billion )
  35. France Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  36. Italy Antivenom Market By Type, From 2019-2024 ( USD Billion )
  37. Italy Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  38. Spain Antivenom Market By Type, From 2019-2024 ( USD Billion )
  39. Spain Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  40. Asia-Pacific Antivenom Market By Type, From 2019-2024 ( USD Billion )
  41. Asia-Pacific Vaccines Market By Region, From 2019-2024 ( USD Billion )
  42. Asia-Pacific Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  43. Asia-Pacific Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  44. Asia-Pacific Snakes Market By Region, From 2019-2024 ( USD Billion )
  45. Asia-Pacific Scorpions Market By Region, From 2019-2024 ( USD Billion )
  46. Asia-Pacific Spiders Market By Region, From 2019-2024 ( USD Billion )
  47. Asia-Pacific Others Market By Region, From 2019-2024 ( USD Billion )
  48. Japan Antivenom Market By Type, From 2019-2024 ( USD Billion )
  49. Japan Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  50. China Antivenom Market By Type, From 2019-2024 ( USD Billion )
  51. China Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  52. India Antivenom Market By Type, From 2019-2024 ( USD Billion )
  53. India Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  54. Australia Antivenom Market By Type, From 2019-2024 ( USD Billion )
  55. Australia Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  56. South Korea Antivenom Market By Type, From 2019-2024 ( USD Billion )
  57. South Korea Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  58. Latin America Antivenom Market By Type, From 2019-2024 ( USD Billion )
  59. Latin America Vaccines Market By Region, From 2019-2024 ( USD Billion )
  60. Latin America Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  61. Latin America Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  62. Latin America Snakes Market By Region, From 2019-2024 ( USD Billion )
  63. Latin America Scorpions Market By Region, From 2019-2024 ( USD Billion )
  64. Latin America Spiders Market By Region, From 2019-2024 ( USD Billion )
  65. Latin America Others Market By Region, From 2019-2024 ( USD Billion )
  66. Brazil Antivenom Market By Type, From 2019-2024 ( USD Billion )
  67. Brazil Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  68. Argentina Antivenom Market By Type, From 2019-2024 ( USD Billion )
  69. Argentina Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  70. Mexico Antivenom Market By Type, From 2019-2024 ( USD Billion )
  71. Mexico Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  72. Middle East & Africa Antivenom Market By Type, From 2019-2024 ( USD Billion )
  73. Middle East & Africa Vaccines Market By Region, From 2019-2024 ( USD Billion )
  74. Middle East & Africa Hyperimmune Sera Market By Region, From 2019-2024 ( USD Billion )
  75. Middle East & Africa Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  76. Middle East & Africa Snakes Market By Region, From 2019-2024 ( USD Billion )
  77. Middle East & Africa Scorpions Market By Region, From 2019-2024 ( USD Billion )
  78. Middle East & Africa Spiders Market By Region, From 2019-2024 ( USD Billion )
  79. Middle East & Africa Others Market By Region, From 2019-2024 ( USD Billion )
  80. Middle East Antivenom Market By Type, From 2019-2024 ( USD Billion )
  81. Middle East Antivenom Market By Animal, From 2019-2024 ( USD Billion )
  82. Africa Antivenom Market By Type, From 2019-2024 ( USD Billion )
  83. Africa Antivenom Market By Animal, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample